Skip to main content

Anti-Rheumatic Rx

      The second day of EULAR 2021 took a big leap in online content.  #EULAR2021 generated 2500 tweets yesterday. Here is a compilation (with links) of presentations were the “Best” as seen by our RheumNow faculty. 
      During Day 2 there were great sessions devoted to RA, spondylarthritis, fatigue and more.  Here are some of my highlights from Day 2.
      RA associated ILD (RA-ILD) is the most common extra-articular manifestation in RA. Its prevalence varies considerably, ranging from 5% to 30%, and is often underestimated since patients only become symptomatic or display abnormalities on chest X-Ray at a late stage of disease, leading to subsequent delay in diagnosis. In this context, several groups advocate for an earlier and more precise detection, using high resolution chest computed
      RT @MeralElRamahiMD: ➡️COMPLETE-AS = obs study of bDMARD-naive Canadians w/ active AS tx w/ ADA or nbDMARDS/NSAID.

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 3 months ago
      ➡️COMPLETE-AS = obs study of bDMARD-naive Canadians w/ active AS tx w/ ADA or nbDMARDS/NSAID. ➡️> overall⬇️in dz burden & shorter time to achieve therapeutic response w/ ADA. But, ADA pts had higher b/l dz OP0143 #EULAR2021 @RheumNow https://t.co/FpJmugsdVw
      RT @doctorRBC: ⭐️All cancer excluding NMSC - 0.9HR TNFi vs cDMARD
      ⭐️Squamous cell CA - 1.2HR of TNFi vs cDMARD
      â

      Robert B Chao, MD doctorRBC

      4 years 3 months ago
      ⭐️All cancer excluding NMSC - 0.9HR TNFi vs cDMARD ⭐️Squamous cell CA - 1.2HR of TNFi vs cDMARD ⭐️No overall increase in all CA: RTX, TOCI ⭐️Abatacept 1.21HR for all cancer, mainly NMSC ⭐️needs more data on JAKs, IL-17, IL-23 Abs#6916 #EULAR2021 @RheumNow
      RT @Janetbirdope: Leave my MTX alone says pt & #rheumatologist if pt has chronic ILD. Acute pneumonia from MTX is NO

      Janet Pope Janetbirdope

      4 years 3 months ago
      Leave my MTX alone says pt & #rheumatologist if pt has chronic ILD. Acute pneumonia from MTX is NOT chronic ILD in RA @RheumNow @eular_org #EULAR2021 #BoehringerIngelheim RA ILD silent killer symposium https://t.co/IQTINuUpVq
      RT @Stiddyo: #POS0196 1 year results of the SELECT-PsA 2 study: Inadequate responders to ≥1bDMARD subjected to #upadac

      Paul Studenic Stiddyo

      4 years 3 months ago
      #POS0196 1 year results of the SELECT-PsA 2 study: Inadequate responders to ≥1bDMARD subjected to #upadacitinib maintained efficacy throughout week 56 (74% of pts completed 1-year) #EULAR2021 @RheumNow https://t.co/xpqhzgeI6q
      RT @ejdein1: #EULAR2021 OP0133 retinal toxicity with HCQ use. ⬆️ risk:
      ⭐️Duration 10-14.9 yr (OR 5)
      ⭐️Durat

      Eric Dein ejdein1

      4 years 3 months ago
      #EULAR2021 OP0133 retinal toxicity with HCQ use. ⬆️ risk: ⭐️Duration 10-14.9 yr (OR 5) ⭐️Duration >15 yr (OR 19) ⭐️Dose >7 mg/kg/d (OR 4.6) ⭐️Cum dose >2000 g Atherosclerosis, age >80 seen in multi-var analysis But didn't have HCQ levels to predict risk @MaxKonigMD @RheumNow https://t.co/DzWWm0U64L
      RT @synovialjoints: No requirement to stop cDMARDs before surgery. For biologics stop 1 dose before and restart 14 days

      Dr. Antoni Chan synovialjoints

      4 years 3 months ago
      No requirement to stop cDMARDs before surgery. For biologics stop 1 dose before and restart 14 days post op, JAKi stop 7 days before, restart 14 days post op, glucocorticoids >10mg/day increases risk of infection in #rheumatoidarthritis Michael D George #EULAR2021
      RT @ejdein1: #EULAR Presentation 3478: Infection risk with surgeries:
      ⭐️Continue conventional DMARD
      ⭐️Some risk

      Eric Dein ejdein1

      4 years 3 months ago
      #EULAR Presentation 3478: Infection risk with surgeries: ⭐️Continue conventional DMARD ⭐️Some risk with biologics, may be confounder and no association with timing of infusions ⭐️Steroids are major risk factor! Esp >10 mg/d ⭐️Recommendations shown ⭐️Address other risks! @rheumnow https://t.co/Bi02d4p9Mw
      RT @KDAO2011: Based on the data, what would you do in a new SLE patient w/LN class IV who is already on a background of

      k dao KDAO2011

      4 years 3 months ago
      Based on the data, what would you do in a new SLE patient w/LN class IV who is already on a background of GC's+HCQ? @rheumnow @kidneydoc101 @Lupusreference
      ×